Studies have also revealed a CRC liver metastasis specific cholesterol metabolism pathway: hepatocyte growth factors from the liver environment activate the c-Met/PI3K/AKT/mTOR axis in CRC cells to activate the SREBP2 dependent cholesterol biosynthesis pathway (17). The gene discussed is MET; the disease is colorectal carcinoma.